AdaptHealth
AHCO
239 hedge funds and large institutions have $1.47B invested in AdaptHealth in 2026 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 80 increasing their positions, 103 reducing their positions, and 26 closing their positions.
0.05% more ownership
Funds ownership: 103.93% → 103.98% (+0.05%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 26
1% less funds holding
Funds holding: 242 → 239 (-3)
12% less capital invested
Capital invested by funds: $1.68B → $1.47B (-$206M)
22% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 103
45% less call options, than puts
Call options by funds: $6.74M | Put options by funds: $12.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$13.7M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$9.83M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.36M |
| 4 |
BAM
Bastion Asset Management
Montreal,
Canada
|
+$6.61M |
| 5 |
Renaissance Technologies
New York
|
+$5.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Reinhart Partners
Mequon,
Wisconsin
|
-$29.8M |
| 2 |
Lazard Asset Management
New York
|
-$18.1M |
| 3 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
-$12.8M |
| 4 |
Goldman Sachs
New York
|
-$6.28M |
| 5 |
Jane Street
New York
|
-$5.34M |
AHCO Hedge Fund Activity: Q2 2026 in Review
239 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q2 2026, worth a combined $1.47B — down 12% from $1.68B a quarter earlier.
Fund positioning in AHCO was balanced in Q2 2026: 26 funds opened new positions, 26 closed out, 80 added to existing stakes and 103 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $13.7M. The largest seller was Reinhart Partners, cutting an estimated $29.8M.
- 239 institutional investors held AdaptHealth (AHCO) as of Q2 2026, down from 242 in Q1 2026.
- Funds reported $1.47B of AdaptHealth stock for Q2 2026, down 12% quarter-over-quarter.
- 26 funds opened new AdaptHealth positions in Q2 2026 and 26 closed out, a net change of 0 holders.
- The largest AdaptHealth buyer in Q2 2026 was Arrowstreet Capital, an estimated $13.7M added.
- The largest AdaptHealth seller in Q2 2026 was Reinhart Partners, an estimated $29.8M sold.
Based on aggregated 13F filings for Q2 2026.